Marketbeat
Published November 20, 2026
Definium Therapeutics Eyes 2027 FDA Filing for LSD -Based Drug, Weighs Two Treatment Paths
Read the full story at Marketbeat
Definium Therapeutics (NASDAQ:DFTX) expects to file a new drug application for its lead LSD -based treatment in the first half of 2027,.
Surfaced by this Google Alert
- LSD